Matthew W. Davis

Executive

US·SEC (Form 4)

Aquestive Therapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 11 Mar 2026 for Aquestive Therapeutics, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Matthew W. Davis: trading record in brief

Matthew W. Davis discloses dealings in Aquestive Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 10 November 2025 to 9 March 2026, the count stands at 2 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 11 March 2026: a share grant, in Aquestive Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.